HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Infographic: EU Sustainability Legislation All In One Place

Executive Summary

The EU Green Deal brings with it numerous directives, strategies and frameworks which consumer health companies operating in the region must work out how to navigate. To assist companies facing this regulatory storm, HBW Insight has produced an infographic which brings together in one place the main EU legislation supporting the Green Deal.

Consumer health companies operating within the European Union are facing an avalanche of regulation, from the revision of the region’s pharmaceutical legislation to the ongoing issues with implementing the new medical devices regulation.

On top of these sector-specific, yet still wide-ranging legislative changes, sits the EU Green Deal. Aiming for “net zero” emissions of greenhouse gases by 2050, the Green Deal is itself a regulatory behemoth consisting of numerous directives, strategies and frameworks.

The European Commission recently announced that it would like to see a 90% net greenhouse gas emissions reduction by 2040 compared to 1990 levels, with a legislative proposal to be made following the European elections later this year.

To help companies navigate this legislative storm, HBW Insight has produced the infographic below, bringing together the main regulations and directives supporting the Green Deal. 

Each piece of legislation impacts the European consumer health industry in different ways, and with varying levels of severity.

How direct the impact of each legislative action is or will be on industry is noted in the infographic, along with how much attention companies should be paying at this point in time. The most critical appear first in red, followed by those that are very important in orange, and finally those that are worth considering in yellow.

Given the Green Deal and the parts of this regulatory puzzle are constantly moving and changing shape, the infographic represents a snapshot in time to help consumer health companies plan for the immediate future.

And immediate this future is. The first three items – the EU Pharmaceutical Legislation Revision, Packaging and Packaging Waste Regulation and the Urban Wastewater Treatment Directive – are in trilogue negotiations between the Commission, EU Parliament and Council, which means agreement is likely to be reached soon with publication in the Official Journal of the European Union to follow.




Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts